BillionToOne: Positioning for a 2026 Commercial Re-acceleration
BillionToOne looks poised to re-accelerate commercial traction in 2026 driven by operational improvements, tighter cost control, and clearer payer pathways. This trade idea lays out a long entry, stop, and target with a 180-trading-day horizon while flagging dilution and regulatory risk as the primary threats to the thesis.